Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04635748 · ClinicalTrials.gov registry record
Feasibility of Collateral Information Review and Its Impact on Clinical Decision-Making
A clinical trial of Anxiety Disorders and Depressive Disorder, sponsored by Mclean Hospital.
- Completed
- Registry status
- 89
- Enrollment target
- 1
- Study location
NCT04635748: Completed study of Anxiety Disorders and Depressive Disorder, sponsored by Mclean Hospital.
NCT04635748 is a study of Anxiety Disorders and Depressive Disorder that has completed, run by Mclean Hospital. The registered enrollment target is 89 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04635748, a study of Anxiety Disorders and Depressive Disorder, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will investigate how review of collateral information sources (CIS) may impact clinical decision-making across the lifespan.
Primary Outcome
Clinicians will find the McLean Treatment Tracking Survey easy to use in their clinical care and we will measure rate of use and completion.
Conditions Studied
Study Locations (1)
Massachusetts
- McLean Hospital - Belmont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2019-12-03 |
| Est. Completion | 2020-03-14 |
What the finished NCT04635748 record still lists
NCT04635748 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT04635748 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04635748 about?
NCT04635748 is a clinical study titled "Feasibility of Collateral Information Review and Its Impact on Clinical Decision-Making". This project will investigate how review of collateral information sources (CIS) may impact clinical decision-making across the lifespan.
What is the current status of trial NCT04635748?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2019-12-03. Estimated completion is 2020-03-14.
What conditions does trial NCT04635748 study?
This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder.
Who is sponsoring clinical trial NCT04635748?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04635748 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04635748's enrollment target sits among peer trials
89 53rd of 84 higher than 32 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
RECRUITING · Phase 4
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI